Puma Biotechnology, Inc.
PBYINasdaqCIK 1401667HealthcareFiscal year ends Dec 31
Reports and events: 311 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0601:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-114167 |
| 2026-08-0620:41 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026311 |
| 2026-08-0620:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026282 |
| 2026-06-1620:06 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-020793 |
| 2026-05-0720:41 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015633 |
| 2026-05-0720:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015621 |
| 2026-04-2820:15 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001437749-26-013671 |
| 2026-02-2621:41 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-005891 |
| 2026-02-2621:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-005869 |
| 2025-11-0621:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033633 |
| 2025-11-0621:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033604 |
| 2025-08-0720:41 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025470 |
| 2025-08-0720:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025463 |
| 2025-08-0701:35 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-03-31 | 0001437749-25-025214 |
| 2025-06-2420:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-25-021153 |
| 2025-06-1320:07 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-020321 |
| 2025-05-0912:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-015648 |
| 2025-05-0820:41 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015533 |
| 2025-05-0820:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015514 |
| 2025-04-2820:18 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001437749-25-013337 |
| 2025-02-2721:41 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-005496 |
| 2025-02-2721:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005477 |
| 2024-11-0721:40 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-033955 |
| 2024-11-0721:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-033929 |
| 2024-09-1613:01 ET | 8-K | 8.01 Other events | 0001437749-24-029206 |
| 2024-08-1513:00 ET | 8-K | 8.01 Other events | 0001437749-24-026953 |
| 2024-08-0713:00 ET | 8-K | 8.01 Other events | 0001437749-24-025027 |
| 2024-08-0120:41 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-024309 |
| 2024-08-0120:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-024297 |
| 2024-06-2420:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-021086 |
| 2024-05-1720:43 ET | 8-K | 8.01 Other events | 0001437749-24-017504 |
| 2024-05-0220:41 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-014395 |
| 2024-05-0220:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014382 |
| 2024-04-2612:10 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001437749-24-013309 |
| 2024-03-1920:05 ET | 8-K | 8.01 Other events | 0001437749-24-008508 |
| 2024-02-2921:41 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-006121 |
| 2024-02-2921:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-006099 |
| 2024-01-1814:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001581 |
| 2023-11-0220:40 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-030028 |
| 2023-11-0220:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-030014 |
| 2023-09-2620:10 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-23-026766 |
| 2023-08-1820:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-024168 |
| 2023-08-0320:41 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-021972 |
| 2023-08-0320:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021937 |
| 2023-06-1521:10 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-017581 |
| 2023-05-0420:41 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-012589 |
| 2023-05-0420:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-012576 |
| 2023-04-2812:10 ET | DEF 14A | Proxy statement | 0001437749-23-011500 |
| 2023-03-0221:41 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-005233 |
| 2023-03-0221:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-005220 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.